Fortress Biotech, Inc.

1.91 USD
-0.02 (-1.04%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Fortress Biotech, Inc. stock is up 9.14% since 30 days ago. The next earnings date is Aug 12, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 30.77% of the previous 12 May’s closed higher than April. 100% of analysts rate it a buy.

About Fortress Biotech, Inc.

Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris. It also develops late stage product candidates such as intravenous Tramadol for the treatment of post-operative acute pain.